ATNM · Forms 3, 4, 5
Insider trades at Actinium Pharmaceuticals, Inc.
No open-market insider buys or sells at Actinium Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Actinium Pharmaceuticals, Inc. (ATNM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Matthew T David | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Matthew T David | Chief Financial Officer | Award | 250,000 | Form 4 | |||
| Adeela Kamal | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Steffen Wilhem Heeger | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Ajit Shetty | Director | Award | 61,600 | Form 4 | |||
| Nicholson, C. David | Director | Award | 62,800 | Form 4 | |||
| June Sherie Almenoff | Director | Award | 18,000 | Form 4 | |||
| Sandesh Seth | Chief Executive Officer | Award | 753,600 | Form 4 | |||
| Sandesh Seth | Chief Executive Officer | Award | 1,027,274 | Form 4 | |||
| Richard I Steinhart | Director | Award | 62,800 | Form 4 | |||
| Jeffrey W. Chell | Director | Award | 61,600 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.